HomeProductsBioactive CompoundsStem Cells/WntSmoTaladegib
Chemical structure of CAS 1258861-20-9

Taladegib

CAS No.1258861-20-9
MDL No.MFCD21609264
MFC26H24F4N6O
MW512.50
InChI KeySZBGQDXLNMELTB-UHFFFAOYSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.1258861-20-9
Product NameTaladegib

Biological Targets

SMO

Associated Conditions

idiopathic pulmonary fibrosis·metastasis·small cell lung carcinoma·cancer·neoplasm
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Phase I Study of LY2940680, a Smo Antagonist, in Patients with Advanced Cancer Including Treatment-Naïve and Previously Treated Basal Cell Carcinoma.

Clinical cancer research : an official journal of the American Association for Cancer Research • Vol. 24, Issue 9 • 2018
PMID: 29483143PMC: PMC6422158DOI: 10.1158/1078-0432.CCR-17-0723

Design, synthesis, and biological evaluation of optimized phthalazine derivatives as hedgehog signaling pathway inhibitors.

European journal of medicinal chemistry • Vol. 138 • 2017
PMID: 28688278DOI: 10.1016/j.ejmech.2017.06.031

Documentation